Patents by Inventor Alberto Moretto

Alberto Moretto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising safinamide
    Patent number: 11103457
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 31, 2021
    Assignee: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Fabiana Mazzara
  • Pharmaceutical Solid Compositions Containing Ibuprofen Salts
    Publication number: 20210030705
    Abstract: A pharmaceutical, non-effervescent, solid composition comprising a mixture of a pharmaceutically effective amount of a ibuprofen salt and a pharmaceutically acceptable strong base in a molar ratio of from 1:0.01 to 1:0.8, said composition being such that, when dissolved in drinkable water for dilution, imparts a pH value ranging from 9 to 9.5 to the obtained solution, which do not cause sensory irritation to the oral cavity especially to the back of the mouth and throat, when swallowed.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 4, 2021
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Lucia Dicorato
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SAFINAMIDE
    Publication number: 20200315969
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Application
    Filed: October 30, 2018
    Publication date: October 8, 2020
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Fabiana Mazzara
  • Pharmaceutical compositions comprising safinamide
    Patent number: 10792257
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide, and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: October 6, 2020
    Assignee: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Deborah Teoli
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SAFINAMIDE
    Publication number: 20200085769
    Abstract: The present invention relates to pharmaceutical compositions comprising safinamide, and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.
    Type: Application
    Filed: May 30, 2017
    Publication date: March 19, 2020
    Applicant: Zambon S.P.A.
    Inventors: Alberto Moretto, Alessandra De Lazzari, Deborah Teoli
  • Swallowable N-acetylcysteine tablets
    Patent number: 9808427
    Abstract: This invention relates to swallowable tablets containing at least 80% by weight of N-acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient, in particular tablets in which the sulfurous odor is absent, characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone, with which the excipients are mixed before compression.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: November 7, 2017
    Assignee: ZAMBON S.P.A.
    Inventors: Alessandra De Lazzari, Alberto Moretto
  • SWALLOWABLE N-ACETYLCYSTEINE TABLETS
    Publication number: 20160113876
    Abstract: This invention relates to swallowable tablets containing at least 80% by weight of N-acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient, in particular tablets in which the sulfurous odor is absent, characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone, with which the excipients are mixed before compression.
    Type: Application
    Filed: May 27, 2014
    Publication date: April 28, 2016
    Inventors: Alessandra De Lazzari, Alberto Moretto
  • Pharmaceutical Solid Compositions Containing Ibuprofen Salts
    Publication number: 20140303250
    Abstract: A pharmaceutical, non-effervescent, solid composition comprising a mixture of a pharmaceutically effective amount of a ibuprofen salt and a pharmaceutically acceptable strong base in a molar ratio of from 1:0.01 to 1:0.8, said composition being such that, when dissolved in drinkable water for dilution, imparts a pH value ranging from 9 to 9.5 to the obtained solution, which do not cause sensory irritation to the oral cavity especially to the back of the mouth and throat, when swallowed.
    Type: Application
    Filed: November 14, 2012
    Publication date: October 9, 2014
    Inventors: Alberto Moretto, Alessandra De Lazzari, Lucia Dicorato
  • Cosmetic or dermatological preparations comprising N-acetylcysteine
    Patent number: 8287846
    Abstract: The present invention relates to odour improved dermatological or cosmetic preparations comprising N-acetylcysteine and a polyol system containing one or more polyols as masking odour agents. The emulsions of the present invention are useful in the treatment of dermatological disorders or cosmetic skin conditions.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: October 16, 2012
    Assignee: ZAMBON S.p.A.
    Inventors: Luca Rampoldi, Alberto Moretto, Alessandro Grassano
  • COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING N-ACETYLCYSTEINE
    Publication number: 20100021399
    Abstract: The present invention relates to odour improved dermatological or cosmetic preparations comprising N-acetylcysteine and a polyol system containing one or more polyols as masking odour agents. The emulsions of the present invention are useful in the treatment of dermatological disorders or cosmetic skin conditions.
    Type: Application
    Filed: July 13, 2007
    Publication date: January 28, 2010
    Applicant: Zambon S.p.A
    Inventors: Luca Rampoldi, Alberto Moretto, Alessandro Grassano